<SEC-DOCUMENT>0000950157-23-000929.txt : 20230905
<SEC-HEADER>0000950157-23-000929.hdr.sgml : 20230905
<ACCEPTANCE-DATETIME>20230905074157
ACCESSION NUMBER:		0000950157-23-000929
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230831
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230905
DATE AS OF CHANGE:		20230905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ILLUMINA, INC.
		CENTRAL INDEX KEY:			0001110803
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				330804655
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35406
		FILM NUMBER:		231234150

	BUSINESS ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		8582024500

	MAIL ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ILLUMINA INC
		DATE OF NAME CHANGE:	20000331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ilmn="http://illumina.com/20230831" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_6c66a6d1c53d442dafd304af52d40566" contextRef="c20230831to20230831" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_430ea15bff904327844b985d1f334a29" contextRef="c20230831to20230831">Illumina, Inc.</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_1a06e0b9e61543ce861604bd1cd2b044" contextRef="c20230831to20230831">0001110803</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_8ce92a17327e4b1aae3cd2d1127a7e4f" contextRef="c20230831to20230831">CA</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ilmn-20230831.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230831to20230831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-31</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 1pt;">[&#160;&#160;&#160;</div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNITED STATES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>SECURITIES AND EXCHANGE COMMISSION<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>Washington, D.C. 20549</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">Form <ix:nonNumeric name="dei:DocumentType" id="Fact_b22632a7597b4e928a1852110f613c76" contextRef="c20230831to20230831">8-K</ix:nonNumeric></div>

    <div><br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Current Report</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_e3b9b5436f724deaaba38f7d6cfa4ee5" contextRef="c20230831to20230831" format="ixt:date-monthname-day-year-en">August 31, 2023</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

    <div><br />
    </div>

    <div style="text-align: center;"><img width="158" height="39" src="image0.jpg" alt="graphic" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 24pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_430ea15bff904327844b985d1f334a29">Illumina, Inc.</span></span><br />
      <span style="font-weight: bold;"> (Exact name of registrant as specified in its charter)</span></div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_611fcc644a5c4a9e958b73bb8ad6acfd" contextRef="c20230831to20230831">001-35406</ix:nonNumeric></span><br />
      (Commission File Number)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 37.5%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_dbba3a6304554f5eaa31d104c132d859" contextRef="c20230831to20230831" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span><br />
              (State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 28.21%; vertical-align: top;">&#160;</td>

    <td style="width: 34.29%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_894fb73bc44b43fda6e0560b0d86e731" contextRef="c20230831to20230831">33-0804655</ix:nonNumeric></span><br />
              (I.R.S. Employer Identification No.)</div>
            <div>&#160;</div>
          </td>

  </tr>


</table>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_f5bf83cf31b5443ba644746c2a83aded" contextRef="c20230831to20230831">5200 Illumina Way</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_f850081a10164b388c845d5c9900f2d4" contextRef="c20230831to20230831">San Diego</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_8ce92a17327e4b1aae3cd2d1127a7e4f">CA</span> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_66df117453c347fd83f5a07c70c79888" contextRef="c20230831to20230831">92122</ix:nonNumeric></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>(Address of principal executive offices) (Zip code)</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_b0bf5a09ef0746f3ba52e48234644677" contextRef="c20230831to20230831">858</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_814bf3b049a145288a2172649fe11fc4" contextRef="c20230831to20230831">202-4500</ix:nonNumeric></span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div>
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br />
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">N/A</span><span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>(Former name or former address, if changed since last report)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5.36%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_ab9699f2b90f48fd97d8347a6b3864ea" contextRef="c20230831to20230831" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 94.64%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.36%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_897f59a111b94388a84fc123724b923e" contextRef="c20230831to20230831" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 94.64%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.36%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_42bf737ae4154d81808eb79811af6ac2" contextRef="c20230831to20230831" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 94.64%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.36%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_caa09c856583462b97b8b305ee2271e1" contextRef="c20230831to20230831" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 94.64%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Title of each class</span><br />
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Trading Symbol(s)</span><br />
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on which registered</span><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; text-align: center;" rowspan="1"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_14aba40cbe4d49d6b3467b72138c3820" contextRef="c20230831to20230831">Common Stock, $0.01 par value</ix:nonNumeric><br />
          </td>

    <td style="width: 1%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; text-align: center;" rowspan="1"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_cc42c0d1c86e4b89b9155099cace65c2" contextRef="c20230831to20230831">ILMN</ix:nonNumeric><br />
          </td>

    <td style="width: 1%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>

    <td style="width: 33%; vertical-align: top; text-align: center;" rowspan="1">The <ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_1e4d1afd73ae442683069e3158f1660a" contextRef="c20230831to20230831">NASDAQ</ix:nonNumeric> Stock Market LLC</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of
      the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_cca9a8185ef5466dbfad0f577e9f7959" contextRef="c20230831to20230831" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section&#160;13a of the Exchange Act. &#9744;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman', serif; font-size: 1pt;"> <br />
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman', serif; font-size: 1pt;"> <br />
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman', serif; font-size: 1pt;"> <br />
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
<div><span style="font-family: 'Times New Roman', serif; font-size: 1pt;"> </span></div>

      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div>
<div><span style="font-family: 'Times New Roman', serif; font-size: 1pt;"> <br />
    </span></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;" /></div>

    </div>

    <div><br />
    </div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.&#160; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
      Officers.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On September 5, 2023, Illumina, Inc. (the &#8220;Company&#8221;) announced that the Board of Directors (the &#8220;Board&#8221;) of the Company had appointed Jacob Thaysen to serve as Chief
      Executive Officer on a permanent basis and as a member of the Board, in each case, effective as of September 25, 2023 (the &#8220;Commencement Date&#8221;).&#160; Mr. Thaysen succeeds Charles Dadswell, who has served as interim Chief Executive Officer in addition to
      his role as the Company&#8217;s Senior Vice President and General Counsel since June 11, 2023 during the Company&#8217;s search for a permanent Chief Executive Officer.&#160; Mr. Dadswell will continue to serve as the Company&#8217;s Senior Vice President and General
      Counsel following the Commencement Date.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Thaysen, 48, currently serves as Senior Vice President, President Life Sciences and Applied Markets Group of Agilent Technologies, Inc. (&#8220;Agilent&#8221;), which consists of
      Agilent&#8217;s analytical instrument portfolio, informatics and cell analysis franchise, and has served in this role since April 2018.&#160; From November 2014 to April 2018 he served as Senior Vice President, Agilent and President, Diagnostics and Genomics
      Group.&#160; From October 2013 to November 2014 he served as Vice President and General Manager of Agilent&#8217;s Diagnostics and Genomics business.&#160; Prior to that he served as Vice President and General Manager of Agilent&#8217;s Genomics Solutions unit from
      January 2013 to October 2013. Before joining Agilent, he served in various capacities at Dako A/S (&#8220;Dako&#8221;), a Danish diagnostics company, including as Corporate Vice President of R&amp;D; Vice President, System Development, R&amp;D; Vice President,
      Strategic Marketing; and Vice President, Global Sales Operations. Prior to Dako, Mr. Thaysen worked as a management consultant and Chief Technical Officer and founder of a high-tech start-up company.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Agreements with Jacob Thaysen</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In connection with his appointment as Chief Executive Officer, the Company has entered into an offer letter with Mr. Thaysen, pursuant to which he will be entitled to:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">an annual base salary of $1,000,000;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">beginning in 2024, eligibility to participate in the Company&#8217;s annual variable compensation program, which is an &#8220;at-risk&#8221; cash bonus compensation program, at a target opportunity
              equal to 125% of his base salary;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">beginning in 2024, eligibility to receive annual equity awards with an aggregate grant date value of $10,000,000, and with the 2024 grant consisting of 70% performance stock units
              (&#8220;PSUs&#8221;) and 30% restricted stock units (&#8220;RSUs&#8221;), with all such annual grants subject to a one-year post-vesting holding period (other than for shares necessary to satisfy tax obligations);</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in order to compensate Mr. Thaysen for the bonus he will forgo at Agilent in order to join the Company, a one-time $500,000 cash payment, which will be subject to clawback in
              connection with certain terminations of Mr. Thaysen&#8217;s employment prior to the second anniversary of the Commencement Date;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in order to compensate Mr. Thaysen for certain equity awards he will forfeit at Agilent in order to join the Company, a one-time grant of equity awards with an aggregate value of
              $3,500,000, of which 70% will consist of PSUs with the same vesting terms as applied to the relative total shareholder return PSUs granted to the Company&#8217;s executives in February 2023 and 30% will consist of RSUs vesting in three annual
              installments;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in order to encourage Mr. Thaysen to immediately acquire and hold the Company&#8217;s stock and align his interests with those of the Company&#8217;s shareholders, a one-time grant of RSUs with
              a grant date value equal to the value of any shares of Company stock Mr. Thaysen purchases in the first 90 days following the Commencement Date, subject to a maximum of $1,000,000, with the RSUs vesting on the third anniversary of the grant
              date, subject to both Mr. Thaysen&#8217;s continued employment and continued holding of the purchased shares through such date;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">in order to ensure Mr. Thaysen&#8217;s presence at the Company&#8217;s headquarters, Mr. Thaysen will be provided a fixed monthly cash stipend of $15,000 until the earlier of (1) his relocation
              to the San Diego area and (2) June 30, 2024, which is intended to cover expenses incurred by Mr. Thaysen in connection with his travel to the San Diego area; and<br />
            </div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20.7pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: Times New Roman">&#9679;</span></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">be eligible to participate in the Company&#8217;s benefit plans and programs as may generally be made available to other employees of the Company at his level.</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;" /></div>

    </div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Company and Mr. Thaysen have entered into a Change in Control Severance Agreement (the &#8220;CIC Agreement&#8221;), which provides that if Mr. Thaysen&#8217;s employment is
      terminated other than for &#8220;Cause&#8221; or Mr. Thaysen resigns for &#8220;Good Reason&#8221; (each, as defined in the CIC Agreement), in each case, within the two-year period following a &#8220;Change in Control&#8221; (as defined in the CIC Agreement), then Mr. Thaysen will be
      entitled to receive: (i) cash severance equal to twice the sum of Mr. Thaysen&#8217;s base salary and the greater of Mr. Thaysen&#8217;s target bonus and the most recent bonus paid to him; (ii) a pro rata target bonus; (iii) up to 24 months of continued health
      benefits at active employee rates; (iv) vesting of all outstanding equity awards; and (v) up to two years of outplacement services.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing descriptions of Mr. Thaysen&#8217;s offer letter and the CIC Agreement do not purport to be complete and are qualified in their entirety by reference to the full
      terms and conditions of Mr. Thaysen&#8217;s offer letter and the CIC Agreement, which are filed with this Current Report on Form 8-K as Exhibits 10.1 and 10.2, respectively, and which are incorporated in this Item 5.02 by reference.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Thaysen is not a party to any arrangement or understanding regarding his appointment. Mr. Thaysen has no family relationships with any director, executive officer, or
      person nominated or chosen by the Company to become a director or executive officer of the Company.&#160; Mr. Thaysen is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.&#160; Other than as described herein,
      Mr. Thaysen has not entered into any material plan, contract, arrangement or amendment in connection with his appointment.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On September 5, 2023, the Company issued a press release regarding the foregoing matter. The press release is attached hereto as Exhibit 99.1.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.&#160; Financial Statements and Exhibits.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> Exhibits.</span></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5.33%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex10-1.htm">10.1</a></div>
          </td>

    <td style="width: 2.94%; vertical-align: top;">&#160;</td>

    <td style="width: 91.74%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex10-1.htm">Offer Letter to Jacob Thaysen, dated August 31, 2023</a></div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.33%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex10-2.htm">10.2</a></div>
          </td>

    <td style="width: 2.94%; vertical-align: top;"><br />
          </td>

    <td style="width: 91.74%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex10-2.htm">Change in Control Severance Agreement between Illumina, Inc.
                and Jacob Thaysen</a></div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.33%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 2.94%; vertical-align: top;">&#160;</td>

    <td style="width: 91.74%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="ex99-1.htm">Press Release dated September 5, 2023 issued by Illumina, Inc.</a></div>
          </td>

  </tr>

  <tr>

    <td style="width: 5.33%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">104</div>
          </td>

    <td style="width: 2.94%; vertical-align: top;">&#160;</td>

    <td style="width: 91.74%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;" /></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
      behalf by the undersigned hereunto duly authorized.</div>

    <div><br />
    </div>

    <div><br />
    </div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date: September 5, 2023</div>

    <div><br />
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr>

    <td valign="top" style="width: 44%;">&#160;</td>

    <td valign="top" colspan="3">ILLUMINA, INC.</td>

    <td valign="top" style="width: 13%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 44%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" colspan="2">&#160;</td>

    <td valign="top" style="width: 13%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" align="left" style="width: 44%; padding-bottom: 2px;">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: left;"><br />
              </div>
            </td>

    <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: left;">By: </div>
            </td>

    <td valign="top" align="left" style="border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">/s/ Charles E. Dadswell</td>

    <td valign="top" style="width: 13%; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 44%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="bottom" align="left" style="width: 4%; white-space: nowrap;">Name:</td>

    <td valign="bottom" align="left" style="width: 34%; white-space: nowrap;">Charles E. Dadswell</td>

    <td valign="top" style="width: 13%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 44%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" style="width: 4%;">Title:</td>

    <td valign="top" style="width: 34%;">Interim Chief Executive Officer, General Counsel and Secretary</td>

    <td valign="top" style="width: 13%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 44%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" colspan="2">&#160;</td>

    <td valign="top" style="width: 13%;">&#160;</td>

  </tr>


</table>
    </div>

    <div><br />
    </div>

    <div style="text-align: left; text-indent: -36pt; margin-left: 252pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
      <div>
        <div><br />
        </div>

        <div><br />
        </div>

        <div><br />
        </div>

      </div>

    </div>

    <div><br />
    </div>

    <div><br />
    </div>

    <div><br />
    </div>

    <div><br />
    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>OFFER LETTER
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.1</font><br>
  </div>
  <div style="text-align: right;"> <br>
  </div>
  <div style="text-align: right;">
    <div><br>
    </div>
    <div style="text-align: right;"><img src="image0.jpg"></div>
    <div><br>
    </div>
    <div style="text-align: left; color: #4D4E4C; font-family: Arial; font-size: 10pt;">Jacob Thaysen</div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Dear Jacob:</div>
    <div style="text-align: left;">&#160;</div>
    <div style="text-align: justify; margin-right: 2.5pt; font-family: Arial; font-size: 10pt;">On behalf of Illumina, Inc. (&#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Illumina</u></font>,&#8221; &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>us</u></font>,&#8221;






      &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>our</u></font>&#8221; or &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>we</u></font>&#8221;), I am happy to extend an offer to you for the position of Chief Executive Officer, reporting to our Board
      of Directors (the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Board</u></font>&#8221;).&#160; As soon as practicable after the State Date (as defined below), you will be appointed as a member of the Board (in your capacity as Chief Executive Officer)
      without additional compensation for such services. This offer is contingent upon the accuracy of your representations and warranties below and on your commencing employment with us by October 1, 2023 or such earlier date agreed between you and
      Illumina (such date, the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Start Date</u></font>&#8221;).&#160; This position is located at our corporate office in San Diego, California.</div>
    <div style="text-align: left;">&#160;</div>
    <div style="text-align: justify; margin-right: 2.5pt; font-family: Arial; font-size: 10pt;">Compensation and other benefits for this salaried, exempt position will include:</div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4166ebe19e864a4bafd1258dbed1d989" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Salary</u></font>:&#160; An annualized base salary of $1,000,000, to be paid in accordance with our payroll policies.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z8c851459114442b3b6049638e2800e8d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Annual Incentive</u></font>:&#160; Beginning in fiscal year 2024, eligibility to participate in our annual variable
                compensation program applicable to other members of the executive leadership team (&#8220;<font style="font-size: 10pt; font-family: Arial;"><u>ELT</u></font>&#8221;), as established by the Compensation Committee of the Board (the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Committee</u></font>&#8221;), at a target opportunity level equal to 125% of your annual base salary for the year.&#160; For the avoidance of doubt, you will not be eligible to receive an annual
                incentive award for the 2023 fiscal year.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z18effab4cb3b4e76ab8408e780af0c96" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Annual Equity Grants</u></font>:&#160; Subject to your continued employment through the grant date for fiscal year 2024
                equity awards for other members of the ELT, you will be granted annual equity awards with an aggregate grant date value of $10,000,000, of which (i) 70% will consist of performance stock units (based on the &#8220;target&#8221; value) and (ii) 30% will
                consist of restricted stock units.&#160; Vesting terms and conditions will be aligned with those that apply to other members of the ELT, with performance goals determined by the Committee in its sole discretion, following consultation with you.&#160;
                Thereafter, subject to Committee review and approval, you will be eligible for annual equity grants with an aggregate &#8220;target&#8221; grant date value equal to $10,000,000.&#160; Annual equity awards will be subject to a one-year post-vesting holding
                period (other than any shares necessary to satisfy any applicable taxes).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z20f7b2eb8b2749a79091750ff3bac39e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Sign-On Bonus</u></font>:&#160; In order to compensate you for the foregone annual bonus from your current employer, you
                will receive a one-time cash payment equal to $500,000 (the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Sign-On Bonus</u></font>&#8221;), payable as soon as practicable following the State Date.&#160; If, prior to the second anniversary of
                the Start Date, you resign your employment for any reason or Illumina terminates your employment due to your gross negligence, misconduct or commission of a felony or crime involving moral turpitude, excluding any such termination that
                entitles you to severance under a &#8220;Change in Control Severance Agreement&#8221; entered into with Illumina, then you will be required to repay the full amount of the Sign-On Bonus on or immediately following such resignation or termination.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;">
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4400adef00b64fb89499c2267ae251ae" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Sign-On Equity</u></font>:&#160;&#160; In order to compensate you for equity awards forfeited from your current employer, you
                will receive a one-time grant of equity awards (the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Sign-On Equity</u></font>&#8221;) as soon as practicable following the Start Date with an aggregate grant date value of $3,500,000, of
                which (i) 70% will consist of performance stock units (based on the &#8220;target&#8221; value) subject to the same vesting conditions as applied to relative TSR performance stock units granted to the ELT in fiscal year 2023<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>and (ii) 30%
                will consist of restricted stock units vesting in equal installments on the first three anniversaries of the grant date based on your continued employment.&#160; If you resign your employment or Illumina terminates your employment under
                circumstances requiring repayment of the Sign-On Bonus, then any unvested portions of the Sign-On Equity will be forfeited and you will be required to repay the value, in stock or cash (based on the value at the time of vesting), at
                Illumina&#8217;s election, of any portions of the Sign-On Equity that had vested.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z01096a0f56bf4da581cfbd24ddf1c93d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Equity Matching</u></font>:&#160; In order to encourage immediate ownership of our stock and align your interests with
                those of our shareholders, if you purchase any shares of our common stock during the 90-day period beginning on the Start Date (the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Purchased Shares</u></font>&#8221;), then within 120 days
                of the Start Date you will receive a one-time grant of restricted stock units, vesting on the third anniversary of the grant date subject to your continued employment and holding of the Purchased Shares, with a grant date value equal to the
                aggregate value of the Purchased Shares, based on the purchase price reportable for purposes of SEC filings, subject to a maximum grant date value of $1,000,000.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z5e5eaabf50194325b87d9a721a70c228" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Relocation</u></font>:&#160; You are expected to relocate to San Diego County as soon as practicable following the Start
                Date but no later than June 30, 2024 (such date, or the earlier date of your relocation, the &#8220;<font style="font-size: 10pt; font-family: Arial;"><u>Relocation Date</u></font>&#8221;), and you will be eligible for benefits under our relocation
                policy for any relocation prior to such date, subject to any terms and conditions of such policy.&#160; In addition, in order to ensure your presence in our offices on a reasonable basis prior to the Relocation Date, you will be provided a
                monthly cash stipend of $15,000 through the Relocation Date to cover associated travel expenses.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zdaf79e480b514f7b82cab7a4bd5b9675" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.95pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 17.95pt; font-family: Arial; font-size: 10pt;"><font style="font-family: Times New Roman">&#9679;</font></div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;"><u>Benefits</u></font>:&#160; You will be eligible to participate in any employee benefit plans, programs and arrangements
                made available to other senior executives of Illumina from time to time, subject to applicable terms and any applicable policies.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; margin-right: 2.5pt; font-family: Arial; font-size: 10pt;">As a condition of your acceptance of employment with Illumina, you represent and warrant (i) that you have not disclosed and will not disclose to Illumina any
      trade secrets or other confidential or proprietary information that, by virtue of the ownership of such information by another person or entity or for any other reason, you may not lawfully so disclose, (ii) that you have not taken from your former
      employer any trade secrets, confidential information, or other business-related items, including, among other things, materials prepared by you, regardless of where the material is physically or electronically located, and you have returned to your
      former employer any such items, and (iii) that your employment by Illumina will not conflict with, or result in a breach of, any agreement to which you are a party or by which you may be bound, or any legal duty you owe or may owe to another.</div>
    <div style="text-align: left;">&#160;</div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Nothing in this offer letter will be construed as a guarantee of continuing employment for any specified period.&#160; Your employment with Illumina is at-will and is terminable by you
      or Illumina at any time, with or without cause. The terms of this offer letter will supersede any previous terms or offers of employment, whether verbal or written, which may have related to the subject matter hereof in any way. All payments paid
      hereunder shall be subject to applicable federal, state and local tax withholding. This offer letter may be executed in several counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.
      Signatures delivered by facsimile or electronic means (including by &#8220;pdf&#8221;) shall be deemed effective for all purposes.</div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;">
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; margin-right: 2.5pt; font-family: Arial; font-size: 10pt;">We are excited to extend this opportunity to you and look forward to your acceptance.&#160; Please return the signed offer letter to me by September 1, 2023.</div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; margin-right: 2.5pt; font-family: Arial; font-size: 10pt;">If you have any questions, please let us know.&#160; Congratulations and welcome to the team!</div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Regards,</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">/s/ Stephen P. MacMillan</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Stephen P. MacMillan</div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Chairman</div>
    <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Illumina Board</div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left;">
      <div style="text-align: left; font-family: Arial; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: Arial; font-size: 10pt;">ACCEPTED BY:</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;">/s/ Jacob Thaysen</div>
            </td>
            <td style="width: 14%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;">August 31, 2023</div>
            </td>
          </tr>
          <tr>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Jacob Thaysen</div>
            </td>
            <td style="width: 14%; vertical-align: top;">&#160;</td>
            <td style="width: 43%; vertical-align: top;">
              <div style="text-align: justify; font-family: Arial; font-size: 10pt;">Date</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      &#160;
      <div style="text-align: left;">
        <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160;
            San Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
      </div>
    </div>
    <div style="text-align: left;"> <br>
    </div>
    <div style="text-align: left;"> <br>
    </div>
    <div style="text-align: left;"> <br>
    </div>
    <div><br>
    </div>
    <br>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>CHANGE IN CONTROL SEVERANCE AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.2</font><br>
  </div>
  <div style="text-align: left;"><br>
    <div style="text-align: right;">
      <div><br>
      </div>
      <img src="image0.jpg"></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CHANGE IN CONTROL SEVERANCE AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This CHANGE IN CONTROL SEVERANCE AGREEMENT (this &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;), is made as of
      the 31st day of August, 2023 by and between ILLUMINA, INC., a Delaware corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>&#8221;) and Jacob Thaysen<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">&#160;</font>(the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Executive will be a key member of the management of the Company as of the Effective Date (as defined below), and the Board of Directors of
      the Company (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Board</u></font>&#8221;) considers it to be in the best interests of the Company and its stockholders to foster the retention of its key management personnel;</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, it is expected that from time to time the Board may consider the possibility of a Change in Control, and the Board recognizes that a Change in
      Control and the uncertainties that it may raise among management could result in the departure or distraction of management personnel to the detriment of the Company;</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, this Agreement is intended to create an incentive for the Executive to remain in the employ of the Company and to maximize the value of the
      Company for the benefit of the stockholders in connection with a Change in Control; and</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Executive and the Company desire to enter into this Agreement, effective as of the Effective Date.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the covenants herein contained and the continued employment of the Executive, the parties hereto agree as follows:</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Agreement Term</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement will be effective upon the commencement of the Executive&#8217;s employment with the Company (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221;) and shall continue to be effective for the period beginning on the Effective Date and ending on the date that is the third anniversary of the Effective Date, provided that such period shall be
      automatically extended for an additional year on each anniversary of the Effective Date, unless written notice of non-extension is provided by either party to the other party at least 90 days prior to such anniversary (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Agreement Term</u></font>&#8221;).&#160; For this avoidance of doubt, this Agreement will be <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">void ab initio</font> and of no effect
      if for any reason the Executive&#8217;s employment with the Company does not commence on or prior to October 1, 2023.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the event of a Change in Control occurring during the Agreement Term, the provisions of this Agreement relating to severance rights and benefits of
      the Executive shall apply with respect to any Covered Termination that occurs during the Protection Period that follows the Change in Control, as provided in Section 3 hereof.&#160; The obligations of the Company hereunder with respect to any such Covered
      Termination shall survive the expiration of the Agreement Term.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Change in Control</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Agreement, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change in Control</u></font>&#8221; shall mean the
      occurrence of one of the following during the Agreement Term:</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">any merger or consolidation in which the Company shall
        not be the surviving entity (or survives only as a subsidiary of another entity whose stockholders did not own all or substantially all of the Company&#8217;s common stock in substantially the same proportions as immediately prior to such transaction);</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the sale of all or substantially all of the Company&#8217;s
        assets to any other person or entity (other than a wholly-owned subsidiary);</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the acquisition of beneficial ownership of a controlling
        interest (including, without limitation, power to vote) in the outstanding shares of the Company&#8217;s common stock by any person or entity (including a &#8220;group&#8221; as defined by or under Section 13(d)(3) of the Securities Exchange Act of 1934, as
        amended);</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a contested election of directors of the Company, as a
        result of which or in connection with which the persons who were directors before such election or their nominees (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Incumbent Directors</u></font>&#8221;) cease to constitute a
        majority of the Board; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>however</u></font> that if the election, or nomination for election by
        the Company&#8217;s stockholders, of any new director was approved by a vote of at least fifty percent (50%) of the Incumbent Directors, such new director shall be considered as an Incumbent Director; or</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">any other event specified by the Board.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Covered Terminations</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General</u></font>.&#160; For purposes of this Agreement, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Covered Termination</u></font>&#8221; shall mean the occurrence of one of the following during the period beginning on
        the date of the event that constitutes a Change in Control and ending on the second anniversary of such date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Protection Period</u></font>&#8221;):</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">termination of employment by the
        Company other than for &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cause</u></font>&#8221; (as defined in Section 3(b) below); or</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">termination of employment by the
        Executive on account of &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Good Reason</u></font>&#8221; (as defined in Section 3(c) below).</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition, if the Executive is terminated by the Company other than for Cause following the execution of a definitive agreement or the occurrence of
      such other definitive event which if consummated will result in a Change in Control, but prior to the consummation of the Change in Control, such termination will be deemed a Covered Termination to the extent the Board, in its discretion, determines
      such termination to be at the direction or request of a party to the Change in Control transaction or is otherwise related to such pending Change in Control.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A Covered Termination shall not include termination of employment of the Executive for Cause or by reason of death or Disability, nor a termination of
      employment by the Executive other than for Good Reason.&#160; For purposes of this Agreement, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disability</u></font>&#8221; shall mean the inability to perform the Executive&#8217;s duties due to
      physical or mental illness or impairment continuing for a period of six consecutive months.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything to the contrary in this Agreement, for purposes of this Agreement, any reference to &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>termination</u></font>,&#8221; as it relates to a Covered Termination, shall refer to a termination of employment which constitutes a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>separation from service</u></font>&#8221;
      within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font>&#8221;).</div>
    <div><br>
    </div>
    <div style="font-family: Arial;"><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination For Cause</u></font>.&#160; For purposes of this Agreement, a termination of the Executive&#8217;s employment by the Company shall be deemed a termination for &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cause</u></font>&#8221;
        in the event of:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Executive&#8217;s repeated failure or
        refusal to materially perform the Executive&#8217;s duties to the Company (other than by reason of temporary illness or other excused absence), as such duties existed immediately prior to the Change in Control;</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Executive&#8217;s criminal conviction
        or a plea of nolo contendere with respect to a crime constituting a felony or a crime of moral turpitude; or</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Executive&#8217;s engagement in an act
        of malfeasance, fraud or dishonesty in connection with the Company that materially damages the business or reputation of the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, the Executive&#8217;s employment shall be considered to have been terminated for Cause only if, prior to such termination for
      Cause, (1) the Company shall have given to the Executive written notice stating with specificity the reason for the Executive&#8217;s termination and the provision of this Section 3(b) that is relied upon, and (2) if such reason for termination is item (A)
      or (C) above, then a period of 15 days from the giving of such notice shall have elapsed without the Executive&#8217;s having cured or remedied such reason for termination during such 15-day period, unless such reason for termination cannot be cured or
      remedied within 15 days, in which case the period for remedy or cure shall be extended for a reasonable time (not to exceed 15 days), provided the Executive has made and continues to make a diligent effort to effect such remedy or cure.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Good Reason</u></font>.&#160; For purposes of this Agreement, the termination of employment by the Executive shall be deemed on account of &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Good Reason</u></font>&#8221; in the
        event of:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">any reduction in the Executive&#8217;s
        annual base salary amount or annual target bonus percentage from that in effect immediately prior to the Change in Control;</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">any reduction or other adverse
        change in the position, title, duties, responsibilities, level of authority or reporting relationships of the Executive from that in effect immediately prior to the Change in Control, including, without limitation, (a) in the event the Executive is
        a member of the Board at the time of the Change in Control, the Executive ceases to serve as a member of the board of directors of the ultimate parent corporation that controls the operations of the Company, (b) in the event the Executive is the
        most senior executive in a particular Company function at the time of the Change in Control, the Executive ceases to be the most senior executive in such function, (c) in the event the Executive performs at the time of the Change in Control
        external duties typical in a public company, the Executive ceases to perform such duties or (d) any other such reduction attributable to the fact that the Company ceases to be a public company as a result of the Change in Control; or</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a relocation, without the
        Executive&#8217;s written consent, of the Executive&#8217;s principal place of business by more than 35 miles from the Executive&#8217;s principal place of business immediately prior to the Change in Control.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, the Executive&#8217;s employment shall be considered to have been terminated on account of Good Reason only if, prior to such
      termination on account of Good Reason, (1) the Executive shall have given to the Company written notice stating with specificity the reason for the Executive&#8217;s termination and the provision of this Section 3(c) that is relied upon, and (2) a period
      of 15 days from the giving of such notice shall have elapsed without the Company&#8217;s having cured or remedied such reason for termination during such 15-day period, unless such reason for termination cannot be cured or remedied within 15 days, in which
      case the period for remedy or cure shall be extended for a reasonable time (not to exceed 15 days), provided the Company has made and continues to make a diligent effort to effect such remedy or cure. Unless the Executive shall have provided his
      written consent, the Executive&#8217;s continued employment shall not constitute consent to, or a waiver of rights with respect to, any event or condition constituting Good Reason.</div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Severance Benefits</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the event that the Executive&#8217;s employment with the Company is terminated during the Protection Period in a manner that constitutes a Covered
      Termination under Section 3 hereof, the Company shall provide the Executive with the following payments and benefits:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severance Payment</u></font>.&#160; The Executive shall receive a lump-sum cash severance payment in an amount equal to two times the sum of (A) the Executive&#8217;s then-current annual base salary amount, plus (B) the
        greater of (1) the Executive&#8217;s then-current annual target bonus or other annual target incentive amount or (2) the amount of the annual bonus or other incentive paid or payable to the Executive for the most recently completed fiscal year;
        determined in each case as provided above without regard to any deductions, withholdings or deferrals of base salary or annual bonus or other incentive and disregarding any reductions in base salary or annual bonus or other incentive that are the
        basis for a Good Reason termination.&#160; The lump-sum severance amount shall be paid by the Company within 15 days following the effective date of the Covered Termination.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Accrued Rights</u></font>.&#160; The Executive shall receive, within 15 days following the effective date of the Covered Termination, a lump-sum cash payment equal to the sum of (A) the Executive&#8217;s earned but unpaid
        base salary through the date of the Covered Termination, (B) any earned but unpaid bonus or other incentive payment for any completed fiscal year prior to the year of the Covered Termination, (C) a pro-rata portion of the Executive&#8217;s annual target
        bonus or other annual target incentive for the fiscal year in which the termination occurs, based on the portion of the fiscal year for which the Executive was employed and assuming performance under the bonus or other incentive plan at the
        applicable target levels and (D) any other amounts due to the Executive from the Company as of the date of the Covered Termination, including any unreimbursed business expenses.&#160; The Executive shall also be entitled to all payments and rights under
        all employee benefit plans, fringe benefit programs and payroll practices of the Company in accordance with their terms.&#160; Notwithstanding the foregoing, all payments under this Section 4(ii) shall be paid or made within 15 days following the
        effective date of the Covered Termination.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Welfare Benefits</u></font>.&#160; The Executive (and the Executive&#8217;s eligible dependents) shall be entitled to continued medical and dental coverage and benefits under the Company&#8217;s group benefit plans for a period
        of 24 months following the Executive&#8217;s Covered Termination, to be provided on the same terms, and with the same Executive cost-sharing, as active Executives of the Company are provided during this period of continued benefits.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Rights</u></font>.&#160; All stock options or other equity or equity-based awards that are held by the Executive at the time of the Change in Control that have not previously become vested and (if applicable)
        exercisable shall, upon the Covered Termination, become immediately and fully vested and exercisable, and any repurchase or similar rights held by the Company or other restrictions on the awards shall lapse, without regard to the terms of any
        applicable award agreement or plan document, and such awards shall otherwise continue to apply on the same terms.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Outplacement</u></font>.&#160; The Executive shall be provided, at the Company&#8217;s sole expense, with professional outplacement services consistent with the Executive&#8217;s duties or profession and of a type and level
        customary for persons in the Executive&#8217;s position, as selected by the Company for a maximum period of two (2) years following the Executive&#8217;s Covered Termination.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payments</u></font>.&#160; Notwithstanding the foregoing, if the Executive is a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>specified employee</u></font>&#8221; within the meaning of Section 409A of
        the Code at the time of a Covered Termination, any portion of the payments under this Section 4 due hereunder during the first (6) months following the date of the Executive&#8217;s Covered Termination, to the extent that such payments constitute &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>deferred compensation</u></font>&#8221; under Section 409A of the Code (as defined below), shall not be paid during such six-month period and instead shall be paid on the first business day
        following the expiration of such six-month period.&#160; The remaining portion of the payments due hereunder shall be paid as provided in the applicable provisions of this Section 4. Each payment hereunder shall be considered a separate payment for
        purposes of Section 409A of the Code.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Reimbursements</u></font>.&#160; All reimbursements and in-kind benefits provided under this Agreement, shall be made or provided in accordance with the requirements of Section 409A of the Code, including, where
        applicable, the requirement that (A) any reimbursement shall be for expenses incurred during a specified period, (B) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses
        eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year, (C) the reimbursement of an eligible expense shall be made on or before the last day of the calendar year following the year in which the expense is
        incurred (or such earlier date if specified in this Agreement), and (D) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Parachute Payment Limitation</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything in this Agreement to the contrary, if it shall be determined that any amount, right or benefit payable by the Company or any
      other person or entity to or for the Executive&#8217;s benefit in connection with the Change in Control, whether pursuant to the terms of this Agreement or otherwise (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payment</u></font>&#8221;),


      would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font>&#8221;), and if it shall be determined that a reduction of
      the Payments to a present value that is one dollar less than the minimum present value that would result in the imposition of such excise tax would result in a larger after-tax benefit to Executive than if such reduction had not occurred, then the
      Payments shall be reduced so as to have a present value that is one dollar less than the minimum present value that would result in the imposition of such excise tax. If the foregoing should result in a reduction in the Payments, the reduction shall
      be applied first against all cash Payments and then, if necessary, against non-cash Payments in order to satisfy the requirements of this Section 5, but applied in a manner that will not trigger additional taxes under Section 409A of the Code. All
      determinations concerning the application of this Section 5 shall be made by a nationally recognized accounting firm to be appointed by the Company. The determinations of the accounting firm shall be conclusive and binding on the parties hereto for
      all purposes. All fees and expenses of the accounting firm shall be paid by Company.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Enforceability</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>.&#160; This Agreement shall be binding upon and inure to the benefit of the Company&#8217;s successors, including any entity that succeeds to the business and interests of the Company in connection with or
        following a Change in Control.&#160; This Agreement and all rights hereunder are personal to the Executive and shall not be assignable by the Executive; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>however</u></font>, that any amounts that shall have become payable under this Agreement prior to the Executive&#8217;s death shall inure to the benefit of the Executive&#8217;s heirs or other legal
        representatives, as the case may be.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; In the event that any provision of this Agreement is
      determined to be partially or wholly invalid, illegal or unenforceable, then such provision shall be modified or restricted to the extent necessary to make such provision valid, binding and enforceable, or if such provision cannot be modified or
      restricted, then such provision shall be deemed to be excised from this Agreement, provided that the binding effect and enforceability of the remaining provisions of this Agreement shall not be affected or impaired in any manner.&#160; No waiver by a
      party of any provisions or conditions of this Agreement shall be deemed a waiver of similar or dissimilar provisions and conditions at the same time or any prior or subsequent time.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Entire Agreement; Amendments</u></font>.&#160; Except as otherwise specifically provided herein, this Agreement constitutes the entire agreement between the parties respecting the subject matter hereof and supersedes any prior agreements
        respecting severance benefits upon a Change in Control.&#160; No amendment to this Agreement shall be deemed valid unless in writing and signed by the parties.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law</u></font>.&#160; Notwithstanding any conflict of law or choice of law provision to the contrary, this Agreement shall be construed and interpreted according to the laws of the State of California.</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Dispute Resolution</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Arbitration</u></font>.&#160; Any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration, conducted before a single arbitrator in the State of California, in accordance with
        the National Rules for Resolution of Employment Disputes of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator&#8217;s award in any court having jurisdiction.&#160; The Company shall pay all the costs and expenses
        of any such arbitration proceeding.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Attorney Fees</u></font>.&#160; Subject to Section 4(vii), in the event that there is any controversy or claim arising out of or relating to this Agreement, or to the interpretation, breach or enforcement thereof, and any arbitration or
        other proceeding is commenced to enforce the provisions of this Agreement, the Executive shall be entitled to payment of the Executive&#8217;s reasonable attorney&#8217;s fees, costs and expenses; provided, however, that if the arbitrator or other trier of
        fact determines that the claims of the Executive are frivolous, the Executive shall not be reimbursed for any of such fees, costs and expenses and the Executive shall repay to the Company any such reimbursements previously paid pursuant to this
        Section 7(b).</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Miscellaneous</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tax Withholding</u></font>.&#160; All payments required to be made to the Executive under this Agreement shall be subject to withholding of amounts relating to income tax, excise tax, employment tax and other payroll taxes to the extent
        required to be withheld pursuant to applicable law or regulation.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Right of Employment</u></font>.&#160; Nothing in this Agreement shall confer upon the Executive any right to continue as an Executive of the Company or interfere in any way with the right of the Company to terminate the Executive&#8217;s
        employment at any time, subject to the consequences of a Covered Termination as provided herein.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Duplication of Benefits</u></font>.&#160; In the event that the Executive is entitled to severance payments or benefits under any other agreement, plan or program of the Company, or by reason of any legal requirement, the severance
        benefits provided hereunder shall be reduced accordingly to avoid duplication of benefits.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Mitigation or Offset</u>.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive shall be under no obligation to minimize or mitigate damages by seeking substitute employment or otherwise, and the obtaining of any such other employment shall in no event
        affect any reduction of obligations hereunder for the payments or benefits required to be provided to the Executive. Except as specifically provided herein, the obligations of the Company hereunder shall not be affected by any set-off or
        counterclaim rights that any party may have against the Executive.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Other Compensation and Benefit Plans</u></font>.&#160; Subject to the provisions of Section 8(c), the rights and benefits of the Executive under this Agreement shall not be in lieu of the Executive&#8217;s benefits under any compensation or
        benefit plan or program of the Company, which shall be payable in accordance with the terms and conditions of such plans or programs.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font>.&#160; Any notice required or permitted to be given by this Agreement shall be effective only if in writing, delivered personally or by courier or by facsimile transmission or sent by express, registered or certified
        mail, postage prepaid, to the parties at the addresses hereinafter set forth, or at such other places that either party may designate by notice to the other.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notice to the Company shall be addressed to:</div>
    <div><br>
    </div>
    <div style="text-align: left; margin-left: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">Illumina, Inc.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>9885 Towne Centre Drive<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>San Diego, CA 92121-1975<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Attn: General Counsel<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>Facsimile: (858) 202-4599</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notice to the Executive shall be addressed to the Executive at the address indicated on the signature page hereof.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Captions and Headings</u></font>.&#160; Captions and paragraph headings are for convenience only, are not a part of this Agreement and shall not be used to construe any provision of this Agreement.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
          Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Counterparts</u></font>.&#160; This Agreement may be executed in counterparts, each of which shall constitute an original, but both of which when taken together shall constitute one agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Compliance with Section 409A of the Code</u></font>.&#160; In the event that following the date hereof either the Company or the Executive reasonably determines that any compensation or benefits payable under this Agreement shall be
        subject to Section 409A of the Code, the Company and the Executive shall cooperate in good faith to adopt such amendments to this Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive
        effect), or take any other commercially reasonable actions necessary or appropriate to (1) exempt the compensation and benefit payable under this Agreement from Section 409A of the Code and/or preserve the intended tax treatment of the compensation
        and benefits provided with respect to this Agreement or (2) comply with the requirements of Section 409A of the Code and the related Department of Treasury guidance.</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">*********************************************</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Signature Page Follows]</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">
      <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold; font-style: normal;">Illumina</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160; </font><font style="font-size: 10pt; font-family: Arial; font-style: normal;">&#8226;</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial; font-style: normal;">&#8226;</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160; San Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial; font-style: normal;">&#8226;</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial; font-style: normal;">&#8226;</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160;
          Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial; font-style: normal;">&#8226;</font><font style="font-size: 8pt; font-family: Arial; font-style: normal;">&#160; </font><font style="font-family: Arial; font-style: normal;">www.illumina.com</font></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.</div>
    <div><br>
    </div>
    <div>
      <div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5d10ef85b2604942a1b9baed51fc20c2">

            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td colspan="4" style="vertical-align: top;">
                <div style="font-family: 'Times New Roman';">ILLUMINA, INC. </div>
              </td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td colspan="4" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;"> <br>
              </td>
              <td style="width: 3%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">By:</div>
              </td>
              <td colspan="2" style="vertical-align: top;">
                <div style="font-family: 'Times New Roman';">/s/ Stephen P. MacMillan </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">Name:</div>
              </td>
              <td style="width: 34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">Stephen P. MacMillan </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">Title:</div>
              </td>
              <td style="width: 34%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">Chairman, Illumina Board </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>
          <div>
            <div>
              <div><br>
              </div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td colspan="4" style="vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">EXECUTIVE </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td colspan="4" style="vertical-align: top;">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;"> <br>
                    </td>
                    <td style="width: 3%; vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">By:</div>
                    </td>
                    <td colspan="2" style="vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">/s/ Jacob Thaysen </div>
                    </td>
                    <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td style="width: 3%; vertical-align: top;">&#160;</td>
                    <td style="width: 4%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                      <div style="font-family: 'Times New Roman';">Name:</div>
                    </td>
                    <td style="width: 34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                      <div style="font-family: 'Times New Roman';">Jacob Thaysen </div>
                    </td>
                    <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                  </tr>

              </table>
              <div><br>
              </div>
              <div><br>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <br>
    <div style="text-align: center; color: #4D4E4C; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: Arial; font-weight: bold;">Illumina</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; 5200 Illumina Way&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; San
        Diego, CA 92122&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Tel&#160; 858.202.4500&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; Fax 858.202.4766&#160; </font><font style="font-size: 10pt; font-family: Arial;">&#8226;</font><font style="font-size: 8pt; font-family: Arial;">&#160; </font><font style="font-family: Arial;">www.illumina.com</font></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div style="text-align: right;">
    <div><br>
    </div>
    <div><br>
    </div>
    <font style="font-weight: bold;"><img src="image0.jpg"> </font></div>
  <font style="font-weight: bold;"> </font><br>
  <div style="text-align: left;">
    <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;"><u>PRESS RELEASE</u></div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;"><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: Arial; font-size: 10pt; font-weight: bold;">Illumina&#8217;s Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">SAN DIEGO, September 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors
      has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Mr. Thaysen&#8217;s extensive background and experience in genomics, life sciences, and technology fits closely with Illumina&#8217;s mission. Since 2018, he has overseen the unit responsible for
      Agilent&#8217;s market-leading analytical instrument portfolio, informatics, and cell analysis franchise. During that time, he drove the division&#8217;s revenue and significantly improved its operating profit. In 2022, that division, Agilent&#8217;s largest, had
      revenue of approximately $4 billion, more than 50,000 customers, and an operating margin of approximately 30%. Mr. Thaysen has driven the transformation of the analytical lab with a focus on implementing a complete digital laboratory ecosystem
      combined with innovative and smart instruments. Prior to leading Life Science and Applied Markets, Mr. Thaysen was president of Agilent&#8217;s Diagnostics and Genomics Group from 2014 to 2018, during which time he nearly doubled that division&#8217;s operating
      profit.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Mr. Thaysen received his M.Sc. and Ph.D. in physics from the Technical University of Denmark. He has a long history in clinical &#8211; specifically oncology &#8211; diagnostics, as well as
      experience in manufacturing, sales, research and development, and innovation. He is a well-respected member of Agilent&#8217;s senior leadership team and has held a number of significant positions at Agilent over his ten-year tenure there.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Mr. Thaysen, age 48, will become a member of Illumina&#8217;s Board of Directors upon joining the company. He will be relocating to the San Diego area from Northern California.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">&#8220;After conducting a robust search process, we are thrilled to have found someone of Jacob&#8217;s caliber to become chief executive of Illumina and help shape and lead the company into its
      next phase of growth,&#8221; said Stephen P. MacMillan, Chair of the Board of Illumina. &#8220;Jacob&#8217;s unique combination of deep technological and commercial experience will be a great addition to Illumina. The Board is excited to work with Jacob. He brings a
      fresh perspective, a demonstrated track record driving profitable growth, and a strong commitment to create value for all of Illumina&#8217;s stakeholders. We are confident that under his direction, Illumina can continue to execute on its goals and drive
      long-term shareholder value.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">&#8220;Illumina&#8217;s technology is at the forefront of sequencing and has set the pace for the industry. I am honored, privileged, and excited to lead such a great organization,&#8221; said Mr.
      Thaysen. &#8220;I&#8217;m planning to hit the ground running and looking forward to working with the incredibly talented teams at Illumina. Together, we will continue serving our customers as the industry standard and driving long-term value for our shareholders
      and other stakeholders.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Charles Dadswell, interim CEO, will resume his position as Senior Vice President and General Counsel once Mr. Thaysen becomes CEO.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">&#8220;I want to thank Chuck for his invaluable contribution as interim CEO during this important transition,&#8221; said Mr. MacMillan. &#8220;We asked Chuck to take on this role, and he has served the
      company well over the last few months.&#8221;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(191, 191, 191); background-color: rgb(191, 191, 191); clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">About Jacob Thaysen</div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Jacob Thaysen will become Chief Executive Officer of Illumina effective September 25, 2023.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">From 2018 to 2023, he was senior vice president of Agilent and president of Agilent's Life Sciences and Applied Markets Group (LSAG) which consists of Agilent's market leading
      analytical instrument portfolio, informatics and cell analysis franchise. He drove the transformation of the analytical lab with focus on implementing a complete digital laboratory ecosystem combined with innovative and smart instruments.
      Furthermore, he built a leadership position for Agilent in live cell analysis through a series of acquisitions.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">From 2014 to 2018, Thaysen served as the president of Agilent's Diagnostics and Genomics Group (DGG) and was an integral part of Agilent's transition into a life sciences company.
      Through his strategy-driven business leadership, he built a solid foundation for growth for Agilent in diagnostics and clinical science.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Prior to joining Agilent, Thaysen was corporate vice president of R&amp;D at Dako, a Danish cancer diagnostic company. Before joining Dako, he served as management consultant at
      Copenhagen Consultancy Company (now Bain &amp; Co). Early in his career, he was founder and chief technology officer of Cantion, a research and defense application development company based in Denmark.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;">Thaysen holds an M.Sc. and Ph.D. in physics from the Technical University of Denmark.</div>
    <div><br>
    </div>
    <div><img width="162" border="0" height="162" src="image00002.jpg"></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">About&#160;Illumina</font><font style="font-size: 10pt; font-family: Arial;"><br>
      </font>Illumina is improving human health by unlocking the power of the genome. In 2023 we celebrate 25 years of innovation, which has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the
      research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more,&#160;visit&#160;<font style="font-size: 10pt; font-family: Arial;"><u>illumina.com</u></font>&#160;and

      connect with us on&#160;<font style="font-size: 10pt; font-family: Arial;"><u>Twitter</u></font>,&#160;<font style="font-size: 10pt; font-family: Arial;"><u>Facebook</u></font>,&#160;<font style="font-size: 10pt; font-family: Arial;"><u>LinkedIn</u></font>,&#160;<font style="font-size: 10pt; font-family: Arial;"><u>Instagram</u></font>,&#160;<font style="font-size: 10pt; font-family: Arial;"><u>TikTok</u></font>, and&#160;<font style="font-size: 10pt; font-family: Arial;"><u>YouTube</u></font>.<br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">Investors:</font><font style="font-size: 10pt; font-family: Arial;"><br>
      </font>Salli Schwartz<font style="font-size: 10pt; font-family: Arial;"><br>
      </font>858-291-6421<font style="font-size: 10pt; font-family: Arial;"><br>
        <u>IR@illumina.com</u></font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">Media:</font><font style="font-size: 10pt; font-family: Arial;"><br>
      </font>David McAlpine<font style="font-size: 10pt; font-family: Arial;"><br>
      </font>347-327-1336<font style="font-size: 10pt; font-family: Arial;"><br>
        <u>PR@illumina.com</u></font></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ilmn-20230831.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<xs:schema targetNamespace="http://illumina.com/20230831" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:ilmn="http://illumina.com/20230831" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ilmn-20230831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ilmn-20230831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://illumina.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ilmn-20230831_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ilmn-20230831_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://illumina.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="ilmn-20230831.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://illumina.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I * # 2(  A$! Q$!_\0
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MLR6VJVS.3%!<;5S^.?Y5VD'_ ![Q_P"Z/Y5Q'@ZUG-KXBCV/&\LQ"$C&>&H
M>U_X4TZ\GBM[/[5*SEG*1^8 ?0'I6?HLUM_PL2(Z?#+;6]Q"WF1.NWG:3P/3
M@4>&]>B\,6+:9?Z;<K=JY)*("7]!5BR:_N_B+9WUY:/;K)"PC1ARJ;6QGW)S
M0!WX 48  'H*=VI*7M0@"BBBF =:3:/2EHH 3 ]*,"EHH ,"D"*.B@?04M%
M"8'I1@4M% "8%&!2T4 )@48'I2T4 %)@>E+10 A52<E1D>U&!Z4M% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "T +0# 2(  A$! Q$!_\0
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MI9F]\0Z;;XSF8,WT!R?Y54=]#EJRTN?0=JGEP1J/X0!4U(HP*6NP\MA1110
M4444 %%%% !1110 4444 %%%% !7._$+Q/;^#O"&I:Y= ,+6(M'&3CS)#PJ_
MB:WKF>*V@DFN)$CBC4L[N<!0.Y-?%G[1/Q1'CC4ETS1G8:'8L2C]/M$O]_'H
M.WYT >Z*-333=,OM;8/?W5NDMR57"AV&< >@SC\*N13G9E#SZ9K;\/A/%7P^
MT2_C \R:RBD7/?Y1D?I7,A&M9BCCY-VWGL?2N*K%QE<]*A-2C;L6%1991)+R
MXR!GM6=>6EM'GS[:&>+L'7/Z]JTRR>8!G&>AJ40I*I#8]Q69TPJ6/.M0@\.J
MYWVBGGA/,./IBLU((9FVVUI%!;@YPB]?J:[[4=$LW;=Y*[AT-9$\4%LQ!Q["
MJNS2I4YD8<F((0B# )YKT/X/:6T]_<:I(F(H5\J,D=6/4_E_.O,/$6J0V5J\
MDC$(.!@<D]@*] T?XO>%/"5GH^EZQ%=:?#<6RRQ70CWQ.3][)'((/7BMJ4=;
MGF5YZ6/:Z*P-.\9^&M2ACDL==TV9)!E=MPN3^&:V8+J"X&;>:*4?[#AOY5TG
M&34444 %%%% !1110 44"B@ HHKSWX@_%OPQX+A=+F[6\U$#Y;.U8.^?]H]%
M'UH [^:6.&)I)76.-!EF8X"CU)KQ_P <?'_POX?>2WTO?K-VF0?LYQ$I]"YZ
M_AFOG/XD_%GQ%XXD>.\N/L6E9^6RMV(4C_:/5C^E>;W$Q9,+\JXH ]!^)GQ=
M\0^/)#%<S"RTI3A;*V8A6]W/5C^E>=[L]*JJV%!SP34T;<4 ?9?[*GBA-8^'
MO]DRL/M6CR&$@GDQ-RA_F/PKO?&7AZ:;?J&E)YEQC]];9P)P/3T8?K7R/^SI
MXK_X1?XF62S/ML=4'V*?T!/W&_!L?G7W.O*X/TJ914E9EQFX.Z/$8+V.=6,#
ML=AVO$XP\;#J".Q%/FU9X1T<8'IUKJ/B+X*:]D.L:!MAU=1F1>BW*CLW^UZ&
MN&T?7(;H&*>)H;J,[)(W&"K#J"*XY1<'9GI0G&HKK<2YUMW4[%D8GGH:P)#>
MWUP, Q*QP6?K^5=RJQS*00*QIHE%PVSC:<TXV%*3M8\L^+4R6<NBZ7 3F1FF
MDYY; P/U-;WBWPA+XD^$>RWCWZCI/^E0@#EDQ^\4?AS^%<=XHW:[\7;>V7YH
M[5%3Z=S7TOX2T_[/;IE1M(P01P171 XJNQ\#0S-$W'XBMC2]<O\ 3YEFTZ_N
M[*9>0T,S+_(UTWQS\&_\(9X\N[>),:?=_P"E6A]$8\K^!R*\^4[:V.<]9TGX
MX?$#2V0C7GNE4?=NHUD!'\Z]Z^$7[0EAXHOXM'\401:7J<F%AF5OW,S>G/W3
M]:^,HY#WI[?,/E.&'((Z@T ?J*#FBO#_ -EGXB3>,/"DNE:O,9=6TK:A=C\T
ML)^ZQ]QC!_"O<*0PHHHH :SJBEG(50,DG@"O)/B#\=O#7A>22UTXG6=04X9+
M9AY:'_:?I^6:^;?B%\7_ !'XTDDBN+MK/3B?ELK5BJ8_VCU:O.6<MTX7T% '
MJ_COXX>*_%4,EHEPFE6#\-%9DAF'HS]?RQ7E<DN22,LQY+$YS45(1^E "9)Z
MU7N6^7K4[' XJM/VH 8I'E@-P?>I$SVYI8\; >#FEZ9 &/0"@"2)WAD66)BL
MD;!T8=B.0:_1'X<:\OB;P3HNL*P+75JK/CLXX8?F#7YVBOKS]C_6_MW@74=(
M=\R:==ED7/2.09'X9!_.@9[VX#+@UY=\2_!#WKG5]&7;J,8_>1KQYZC_ -F%
M>HJ?6J.JWUK91YN9 &/11RQ_"I<5)6949N#NCY[TW6)%C9'R)!P0PY!JY'/^
M[DE8X&,YKHO&.A0:E+)J>DPF*<?/+%_SU']X#U%<#J=R\D,>GVAWW=V?*C4>
MIZGZ <URN'*[':JBG&YSGPITMM6\=76I2#/F2.P/L#@5])73G2M)$R*I?<%
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/ *\E_F:**0SO**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139909482291888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Illumina, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001110803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0804655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5200 Illumina Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">202-4500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ILMN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ilmn-20230831.xsd" xlink:type="simple"/>
    <context id="c20230831to20230831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2023-08-31</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230831to20230831"
      id="Fact_6c66a6d1c53d442dafd304af52d40566">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="c20230831to20230831"
      id="Fact_430ea15bff904327844b985d1f334a29">Illumina, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20230831to20230831"
      id="Fact_1a06e0b9e61543ce861604bd1cd2b044">0001110803</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230831to20230831"
      id="Fact_8ce92a17327e4b1aae3cd2d1127a7e4f">CA</dei:EntityAddressStateOrProvince>
    <dei:DocumentType
      contextRef="c20230831to20230831"
      id="Fact_b22632a7597b4e928a1852110f613c76">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230831to20230831"
      id="Fact_e3b9b5436f724deaaba38f7d6cfa4ee5">2023-08-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber
      contextRef="c20230831to20230831"
      id="Fact_611fcc644a5c4a9e958b73bb8ad6acfd">001-35406</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230831to20230831"
      id="Fact_dbba3a6304554f5eaa31d104c132d859">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230831to20230831"
      id="Fact_894fb73bc44b43fda6e0560b0d86e731">33-0804655</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230831to20230831"
      id="Fact_f5bf83cf31b5443ba644746c2a83aded">5200 Illumina Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230831to20230831"
      id="Fact_f850081a10164b388c845d5c9900f2d4">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230831to20230831"
      id="Fact_66df117453c347fd83f5a07c70c79888">92122</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230831to20230831"
      id="Fact_b0bf5a09ef0746f3ba52e48234644677">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230831to20230831"
      id="Fact_814bf3b049a145288a2172649fe11fc4">202-4500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230831to20230831"
      id="Fact_ab9699f2b90f48fd97d8347a6b3864ea">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230831to20230831"
      id="Fact_897f59a111b94388a84fc123724b923e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230831to20230831"
      id="Fact_42bf737ae4154d81808eb79811af6ac2">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230831to20230831"
      id="Fact_caa09c856583462b97b8b305ee2271e1">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230831to20230831"
      id="Fact_14aba40cbe4d49d6b3467b72138c3820">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230831to20230831"
      id="Fact_cc42c0d1c86e4b89b9155099cace65c2">ILMN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230831to20230831"
      id="Fact_1e4d1afd73ae442683069e3158f1660a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230831to20230831"
      id="Fact_cca9a8185ef5466dbfad0f577e9f7959">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ /#TE5Y>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
M/#TE5R0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ /#TE5P=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  \/257AC1<
M\N\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  \/257F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( #P])5?>2[@:0@0  (00
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  \/257GZ ;\+$"  #B#   #0              @ &&#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #P])5>7BKL<P    !,"   +
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4!08     "0 ) #X"  #F$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://illumina.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex99-1.htm</File>
    <File>ilmn-20230831.xsd</File>
    <File>ilmn-20230831_lab.xml</File>
    <File>ilmn-20230831_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ilmn-20230831_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ilmn-20230831_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ilmn-20230831.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ilmn",
   "nsuri": "http://illumina.com/20230831",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "c20230831to20230831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://illumina.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "c20230831to20230831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://illumina.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000950157-23-000929-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950157-23-000929-xbrl.zip
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MZ8\/#T:B-^ITQ"CZ/][#@_9X\,VV\= MMMW)3]S)9[1;,>  QP8<LS5[^IT
MPF?H L%.C:4!A-@<8RMP>/I@+0%:B*$3=/1@5^<<<98Y.@WP/.YDJQ'8#9A7
ME.9E_%G3T\NUFFCPQ\'33)RGBCXT66WK;AKO;XK*G4P$C^#&5.8@:C#X:;'3
MQ<?KM7$"^+'"X&Z79HKJ;4Y0-#P,^)+*HA!BR2=^LC]73;P>,O"<&7A\$P&.
M6XZQ1YDA0Q)Q(Q(F?D?Z Q7!7_BI<H8=6^I*VL<XR%[O(WYPU_B-DE9%PP21
M*H.B%AEDJD!];F7!<@SB&X&LX=XDK/)=>JEC?(94\LN3)UV3M#^%ZN^.1!SS
MH!^"UN^+X2$/1OW.2 Q''1YWPO'A5O5O5?_W4/T7OY>H*?Z!0;!9H_ZORN W
M$18N#:)=H%V"_JM%Q,54JW(RI=T[P9ELX(L;>MEBK*H!82$@'6 #LK7:'K1R
M,Q=!"V&P:A%I3D-^).J>"03?$P2F!M<-3TIA7=+.PB>%[[.IA!!\5[YAP\Y/
M=B' U\!NQ+NYT !=2DK0%"K\PE#+&K:+.I22!C4U;[6QSUS1BF\H -V5,/V!
MFWZ=,:S6TV!MM P1Q]IR7C'_&^Y2ADGHU*8R8*C-GIA%O@8%"L83.8JI EU?
M3-%:@'6=WVE8B=0TI([R1/$$LT.XH$T050;0V3PP^$@/HT I1L!W+1":%O T
M2=0,@47LRL3F7^P*P%&'T2HMK@$V07FJ%C,+.5PLJ,6-%#9E QAI!61NRDAE
MD5"LFH)"\K!.4-8R<$5Z*J-:DZ$JX[9>(BU(-40XR(S8HZV1*U/LW3B63E6"
MQF.5(, .J4"$+-> DVA<Y\Q,.<@*R\#D&H.&'.9&A\3$<[I?]Z7XK3!O_A06
MM=>)AT%/!*.@-^R/^7#<&7>'@TX<'P0\/!B+K47=6M1OFQ:!I?8^9>#S9^4Z
M4_H+Q$,ZLB6%*N81C>H"_!834 J5=XY3L5BKU%G?4FLTN-;VHEZ$RZMZ@G1-
MY8&3EBF .RSD9HJ9%3+:"PTVL.KK&<*4NTBP"%5@=5M^6%^56)B*9F7"J]9?
M8I@"E" 1$1\Q LT>T@MPU<;FFE8IXF9S.7%K)$!G KB6L#5GQIJ*.=SF!NL\
M>I&BMZ8/)C KHZ)25#[21"N#ZG@"PB? =+98"M80P"Q![RM;5I#&N"H29[%(
M%"R(=S2R268W*KE!(J1*(X]*G<NBC 0FIS$/C;=(\6/%P ,ER0'AQ1H/*Z.N
M @*:; .$A9IL>IFA/'+/]'.P*!.RX^? -:T2=E4]>H95#$35FT3X".89$W@P
M)9G11043R)TU#+%&8ZBIBP'+,-RZ#G$)=WFJRJSPOD=#@IBEOTQ3$4D@>S*O
M"0@A;WEHD4>A6-#BM=FX5S&HPN^.QT)BZ@-- /<;R]&]&O3^!/Q2>\:BB&TM
MR"/G]+4F]L#X>U0:R?KA\5,!&/1 NU9:Y#]\_EH N^)9?3?XPMX9&_>ZO=YK
M@?):).[3:#!J0Q39[H/)>BW0?>"W"[B&AX>O!:X[QR\_/YO-VM()9QMLTQJ'
M;47%.-?ZW>?+#Y=\(MZ!L?QR!G]5[G680%B#.[F85@XG^&P><7<%;A<JK?RN
MAGI:MT0U?0Y7]@*\M$<!(KB)R8S/3<,G/)EJEBF(CB(8X3Y4,U@(CE@_OV6=
M_';)OP_(4]MSUX":4Z>:>OBH5X_O/N ?>)J'7\#H@S7=6[Y5I\/._33]JLCI
MN:O,_4X'J!1W.L%A/PY&X_YX'((T#KGH#;I\&U1M@ZKO$U39/.5J5+59;+62
M8XR%Q+S:LT56-C\$/FQSI>>+J%;P]R'5QI&4BWTV38T>M :+S.@:0KQPJK26
M)J,PCP.1?7ZLENC$-C3,;OG((N%44+J^^GPG##YO[&:^^'B]IK)Y<&+*W#-K
M99O@)B"UD4@0 &\:N@VI-RE/$O"E%QU/,.-I/0-\AW0]F &NZ !@VR!>9J:
MU3 Z,YZXL=2&,O-"U*)C['-SD5:-ZQ57[DSQ+^+O^T+G#6-EBCK7I+ZE#LL4
M, &.&1<Q(IH4+]KYU\2(+MC$<+C,D#( -W5?HG@L#7#%#A^4+O0 LN7A<)5$
MLX5DM]S @!TS*DVIMEN(%_2%E - X5A&M=I5S#W1< ]TA\>&B01DGW+GF"
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M4A>+J*@1@)-IK0\*L%W2K@-QL&O^H>89:L[QAMT^86VHI4<*D3,BE? 9MK1
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MJ4_@*T-^]E4>\+./NLL17UQ]X.#A][[E/YWLX[]+0!_</[KP/U!+ P04
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MYJ/A<5GE\9<Q\!PV =\/\Q*^H%<+50'5<&/!M_@N$;<AYQ0^R;-,I8=+R"!
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MZ"TBC^.Z*'!W)C7]A5^$7&'..&1GY&VC! 0K7H!-7]'7P+'07T$,0L!7:>
MTK#:%E>CFO &EM,I;%=: U"4T0# %G$9CN' +F SX8!TQF<Y20&:0.F/_E.1
M5T9=^\32@4T(/HQY<7L, F_'PO//IH6G=*CG0[L/SG'G#F"I: @=VPQ?KC,T
M1/HF09O9S,22P9\0$Z&LBPM2>G'MKJ8ZU%S"M5D(MSV$:K&[G*I%9^&73KM
M03NM"[!A5<].BQ8(DG5)T9;^AB$G2F:^^<0R0YDS(,^L>66VV+7"I*,+/S Y
M[P@X/_:> R?$=8B[=;CLO=D[V3N^TRB>3Z\3*<\[<SHJM$S[M^N[-*U1.MI=
M>L<V+>XJ;OB^9],T#<!.>'9XWP'L[VYO"SL;\;N<+<O /DN'<.&?-UJ-\D@<
M'XF#W9W=W649Y;E*S4_/]Y]O@9JUM;>_O;TLHWLKKYIQ_?3LV;*,:^[W[?<O
M+R^WM&'.+=!S^P[%M@B+4UF6/Z^]/OOT]I,<J=>@8'\Y@O\XKV\,%DV!.[D:
M'XJ)+,!,W*SRJ9VX>0*_!DO-B:Y //5UX9J?PI/- 3[:E$,062^$3"_!=/(:
M01=[ ;H[G&()?&%^<"WP"%Z(O>F5V)Y>'8+*EE1C',KV?Q["N M0XS;-,Z#F
MV(BF77S5BL?7;_%_\+:,OXR*'%2_S?:O?#JL74O3:Y2.!>DC]]3TUEZMRXWO
MK=>MO4)5>J**$7J*"L+W\A1L4M*209VY'.LXM.%(C6FX JVY >O7K&NCJH+8
M,UCBZ]"B4<!!_<I2\C5)>#0H=:(-," S-M[--Y=C4-9"U#@!,Q6[R2\S@2H4
MM3HH*PE?$"1!#P/;P5FC:&BB,8#MX7S"#VG4<D(&V30OV J!,6JP3F& E8)W
M0O2@ FNL9+_"QN'#ZKOWYZ_!$O 7DS@EM?:.B]<P&8@N5976\C-@#_EQL#W'
M;?0<[%-@$^0C:'T3> 9LT(;CEG_1XB59-!G_6>M26W.908<8U@SW(=!^K*>,
M@\1L\:2P\9L5LPY7L:ZS.*T1LHS(C,_K2J1ZHBL2,9&8YI>*MM=%7JD-ZY*"
MMY!%".D$@5.H-CC0O\$I7F+6PQIN$#!>8_3A"3.UMIGOZ9[AAXP[6.!BY^EZ
MLK'^=,,. IZ#349NBI.KF&V_HYAPH9V#IWL(@'C,.R&\=/DY+UD"SF-V L9!
M5U&JG ,W\<(,?#X@K$DVQ#8N87B)3ZZ\Z',Z-J<:LTJ)XD( (RJOHX$:8C@@
MB?UF*(37:]2$0,%3,/S%8LCOLKB>#-# =X$5O>$.2I;D3< #&UB\1N= 0X6)
M_",OC,?>.>8/[X<AT_ LJN>-*5I LV,0 A>J\%HU/@T>OJ5^A.0GPK-^@GBT
M6YG!K)E_GZ#P58J(%8^9R& @=L7%);+2%*?(8D"23*)7K4MAJ(<5R1<T[<7Z
M_O9_.IG0LW(1,T_0B76N.%<J>DD1U^UIX!#FN^Q"0RV#T'!* </SB!/KH>95
M=/R_M4!2/@3*^W1)4=ZNLZ!<=J9<!L/J_E+Q%U"Y"NE#R;X#\=O@VMW%OQ'9
MOB.DW>/Z#@4YN;A-"[R_Z6QH3KZRUQG7]967"K[I^,9)1%,?BSW).YZSGG/\
MQ0-[3 PNA+]?V-[22["W*L_/!TOHN9Q9X#<,9%$+SS9$K6%Q&T3694_P1Q [
MZWM P28WL;0/?[@_S/+_6.O?.,7A51G'><WN^X4QP"\Y"*\S"HBX"QO$E@T6
MJ94L+-+!QO1$5@-OR(AA1H;ZC7XU9Y?1YO"D/COAJ25>.,G$T1P1Z7R;)B@J
M.$?LDI*XYGZ\;_E<8+,.AHQG0SV9T! I@*:)%.X-8![458/SF7A%;L +%NCY
MCB%!CQEMM$Z",TFPL[Y0B]Q0HN+#S.BG%&")81V)+N-",?T3Q<VK,B! %3:'
M,?_<$ML9QE(MU)\U8C!$Z2!>JGM<>L F&<TE$_D2PZ\I(H5#C$V<&)^KG5:6
M*%[GJ)?TK*D@F,R(D!+S14D[QM!C:?AAX,*@$)U0LB*LX8TN)0?+1]!+ 60/
MV[>+V)%8OJ *-Y$G8+ZY^M=,YV:M#R9IT@2 34"I@[%/YH2()35!9PD%1%J2
M3,>S$D,,D8PX#?@)-E.& 8+(CR!@=&%B_RF8$AF0 M*L!HFZG+ZBK6M).8%7
MQ^42<>5I7B$ Y;!-$)JP>!SK9>.D"U1,"0<-5W5XPZIS9-Y0L<2$!A?&!E6O
M]A]YX*DV86N*0?J^O1<9AJ$A\EOS]QY+\E#%7]AT2DP4,0@2IL*4JKC0<8\6
M9UD3E\P T\CN9%(,W6&^MWUPU(! ,"<,A3W#$ZG&DS%1# L_?\98):/!"T_2
M2Q:5LA9T9YW:JR"851#,*@AF%02S"H)9!<$\PB"%^Q_ OI'QUMH)7X'<=I2B
M&Y,L6B:X\R\Y$]1O\%M@7WX00) S\2.BG4=+P)W]+%"H*1>D&4J=<M:S[P8?
MUJ5,.8$7&(!#;6YEE5F$P";->>9H8/-6P(,YVRJ-F6:\<%=QC55VY*!$6V2#
M%%_&V;D/=:7)P]\;9]6+3SQP\,2#\,[KI>6=N- H$B@Q$4P?% T-[[!-#6<,
MIX&E.8=D8$",ZF;B4%NJ,=4XQF:HTCR;<5/\ B;A [L 2X+T@Q<3]8,"X,=+
MNZHJ&]DB!PAT(MY=><N*51#2(>Q?S">+P/25=6)*)8QSV,#5K"]4QI<%Y'?S
MY$DBL:@29X$-L"Z6D0(@FNHJQ$ZYA>4#N]N #+LI"[!9*&+MQM.W+YP#ML58
M7F E!)7Y8+F''V(LK!Y&[>#2\*1V%1;PFTBL[VSTG/34TPA&YW!EKQY,F%A;
M5IQ72.MJ8B1B NRHR@D)]DZY"#=I?W VK=_E,3I5)G!TV;SD0J48C(&IW%PL
M9'UW V%ZFK3?L=<%EK: (T; ">Q2I0H!NP].E=S4"L@"\&]GG]-]N;S)F*AB
MH!H.PS%4:,BF4CDMR47 <8G]$X=7L9FXQK4E[L9#BZ)*YP_?.+CIE9W]32SN
MQ"-U6<_7?1W+S,15VUXM#5SG!I,RDXZ:6.V8(L,:Q_K0#IG$,;;7,&V8RVU&
M(P>IXK(PZS@(+&AQ%2MXR?2U$>2.^_PVEK;"%:RQS7DO60GY@F6)$@T;&+>-
M&D*/W#8E&5MJ^,-\*-CV<83H/I3G\K:&"M4:N,$-VTE);LR2[^*-U4'FI?BA
M#9-E<,.SQR&I8YLMTBM O4CH+*M! QR@A +K!&T'.6$>*.PO*Z"5 @;*L[JT
M@9:@9%BI+DFW,4+C<9L/2Q%I$2ZQL_!D@A%4WE:*'<4K+AIFX@>H!&MD[+Z(
M+ =4E,A32$]2V(24 ")K.(0Y:)DT2$S'@1.4JR' -V,]+7M\LO=BBTC<D)VP
M+C="%*,=#.$Q=ZO@'A=#,V[YRIA <T81MDK!W267?RBX5%2[\8$MO]>)BZ]3
MZ NCV::R8&]I4QC2QLUAIZRUYU-3RZD;5X\*W+53#V7I)"^!S52&Y%;-6YF)
M/-!Q#?N]*1969\Q1]Z./23R;VS=I%;8OF%)\[90,/%+>:E#>*7)E?'X60)E-
MR8_-<Z\'J8XQ2X6I.F\F%IKQ41+4=Y,-+^7)*$EV-\JJ*O0 +"U2V)C%AS(V
M\9&^J1!0K#THYJ\F<:)?@/Z8QKI>#B&*4BR/C4SQK(V>.#5G=ECCC>(94..:
M"P:#C,MB/066FZ:2@VZ=-0Z*V 2S6 B_>[HO8)#*,Y'NUMCM!>M7&/HK'_/*
MQ[SR,:]\S"L?\\K'_$/!NB&4X2$0<V!>N] !>C*OC0;V;6,I7>#7:GO?%?:-
M;X!]+6+K0-U% ;?M?,^E@&UOQFLM';XY;.NJ["T6M!6_,9WFLJP;Q+BQGCNZ
M[ARW9=Y31;@)Z?9RH4U#,-:(G9"7$G.^D*5,(<66(Y/#9PT@2'50. ,B=&SZ
ML=C+FD:ZMYQII)]=)<O7IGSETOD"WX70@)SG$+JNPFF8'G-M(4W"!V L&8=7
M=#(:YY>V#(M3V*J:48]WT&RVME_0CKI)S9E*FE!88'0AM;;_/P'B]W=@--OD
M$Z](CVOFO$>T%BI6E$0E0"&>;I;U!$^4L5= UJRP#0U@W%W]67.44'7)5T&P
MX,;/052N'VW,TPK&*MOD[*QJ/JP/)TY:EV+]]48(=HSHG@*2QAWMYMHN N=
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M>]Q6]J>73P9Y,J,?QM4DA1_^#U!+ P04    "  \/257:G7^CE4,  #L*
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M&XO,$?;P'**Y\,R/.7(L<\.5R'7T^">ZX(QIL '7SQ45$,QU@A5]80;4+"=
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MX/<^(ZXQ=#H]YXVPGR,94%7&,IF5-AROY\ !CN7F_%7;:,3]Q5VS3TX^7!-
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MP_+:%A1K[&UP**+H&]V0O'FU]\Z;[JR<K<'C(]DJNMDOLM6):E21)71(!^;
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MK^M>W2PR!EZ(D#3G8R_R0P\0CO.$\NG8*R5$$E/JW5R_?7/U#L)/A!.!%$G
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MP!Q1++M$7@&J98_8DN(ND9V[672+NGEW#ZO;DI.I>9+M#K\)8T*LH:#A@=$
M1A?]=:C.&M0I\=?+J0K1J?S.WZ[Z'4#[F79,XA9BOJ##F?1CDWX<G:SB+!#F
M!_M( =;;A#V#X26,PFY5WWIR'AG5 4S@\Z-#[GM5]OAUL31]QZY^%6E]6$&R
M*!CB2.5B>:^_CQ^!-LO=BN24B6@_ISO5R/E7]3&/\4ZEV?>,/SEZW^/9^9]E
MGYC7D/9;KH38QU%%=OT74$L#!!0    ( #P])5>O#GX^?P@  '18   5
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ME5@U:AN#:W!V2[&]$SO2MES!-],@6=0CVJOVF;QP.Z Z,*3)16'U[JI"+N*
MT$="LP'<I>S:_8QLV#GD^8PLX$OI6AE2M51D-*X9J[_;RJG3E;U^JAU$%4G*
M5RC3(D)1H4<\H0\%50\(\DT[!A67-5DNL1K]=%5HYVM,5V&\^DC)4_IP1M:/
M?@Q?[%N54F$9E(T+"O1U6TBV+NP%9,X4A2,4*)>@0M.'6K'O+7G1)D"U 2;)
M-6'Q[:H63A<+QF!2_'<9QG@"5H)%)]4!J&M<!8"KVQHP=V"O %.>X+\(O!(?
M$)>@Z[@79PO;GI(7+#]$/Y BLV_T/!SY7DWRO9KD>ZV0[[5-OO>-Y'LUR+]_
M(OTDWZM+OO=R\KTJ\KU#DS^M2?ZT)OG35LB?MDW^]!O)G]8AGVU83X_ZT[KL
M3U_._K2*_>E!V#]C'Z_I/7F*;>3K*HC[LLH5]7O/5IC7[&L1KV1IO/,X_U;,
M%3TB'=A%B'-XR2V4[Q- QE6_C@G/OF)?TQM*OH:Q!EP=*<2Z)G4%O&+<"O5P
M'[70AU(U_G>WA82L1T5@VF.H$BQ[82D')0NL"="YZT-_?MO)>MR7)>!!7TB<
M'?%SPW8.]Y)WO6-]*44_T.?!'N&M[AAX@-=7V'9T+V[M@H?VLE/'^-Z0)/6C
MO\-'XV\%;$((947H"FC)MA6LH1YJP:TG:HCG$L0TO;FY;]U7"'CC#EBPEW)
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MJV<_"A?$Z'7R8.!)WX9,@^B>%$9NR!VO&TY)0@KIU>^HP((@^V.9'V!V> <
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MDZ98*!,"*"3L^5RQT&6RRF5/G*S"<-B=SKEO?[]RWDJ X,'? %!+ 0(4 Q0
M   ( #P])5>4XVM:&!(  'UA   *              "  0    !E>#$P+3$N
M:'1M4$L! A0#%     @ /#TE5V@<_]/K)0  =08!  H              ( !
M0!(  &5X,3 M,BYH=&U02P$"% ,4    "  \/257:G7^CE4,  #L*   "@
M            @ %3.   97@Y.2TQ+FAT;5!+ 0(4 Q0    ( #P])5>YB,OT
MU1L  (:@   +              "  =!$  !F;W)M."UK+FAT;5!+ 0(4 Q0
M   ( #P])5<)'D<G1 ,  #D/   1              "  <Y@  !I;&UN+3(P
M,C,P.#,Q+GAS9%!+ 0(4 Q0    ( #P])5>O#GX^?P@  '18   5
M      "  4%D  !I;&UN+3(P,C,P.#,Q7VQA8BYX;6Q02P$"% ,4    "  \
M/257Y@2[ -L%  #Q/@  %0              @ 'S;   :6QM;BTR,#(S,#@S
M,5]P<F4N>&UL4$L! A0#%     @ /#TE5ZC-512_!0  5@8   H
J     ( ! 7,  &EM86=E,"YJ<&=02P4&      @ " #> 0  Z'@

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
